Maxion Therapeutics
0 followers
‌
Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins.
Industries
+2
Headquarters
Employees
Links
Org chart
Arndt Schottelius
Collapse
John Mccafferty
Co-founder And CTO
Sohaib Mir
Senior Investment Principal
Thomas Weaver
Non-executive Director
Tim Funnell
Partner
Aneesh Karatt Vellatt
Chief Scientific Officer, Board Director
Sylwia Mankowska
Director Of Operations
Lisa Negus
Financial Controller
Lucy Edwardes Jones
Board Director
